SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-032161
Filing Date
2024-08-14
Accepted
2024-08-14 16:06:05
Documents
70
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1591136
2 ex31-1.htm EX-31.1 14477
3 ex31-2.htm EX-31.2 14730
4 ex32-1.htm EX-32.1 9161
  Complete submission text file 0001493152-24-032161.txt   8162594

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE qlgn-20240630.xsd EX-101.SCH 64129
6 XBRL CALCULATION FILE qlgn-20240630_cal.xml EX-101.CAL 60601
7 XBRL DEFINITION FILE qlgn-20240630_def.xml EX-101.DEF 311454
8 XBRL LABEL FILE qlgn-20240630_lab.xml EX-101.LAB 484152
9 XBRL PRESENTATION FILE qlgn-20240630_pre.xml EX-101.PRE 403915
72 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1434428
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37428 | Film No.: 241207557
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)